Proteomic study of Alzheimer’s Disease
Madhavi Bhatia, National Pharmaceutical Education and Research, Guwahati Alzheimer’s disease (AD) is a progressive neurodegenerative disease and is also age-associated. Approximately 5.8 million people are affected by this disease in the United States. Typically the onset of AD mostly occurs after the age of 65. The primary clinical manifestations of the disease cover profound cognitive […]